- Home
- MTR vs ADIL Comparison
MTR vs ADIL Comparison
Compare MTR & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.30
Company Overview
Basic Information| Metric | MTR | ADIL |
|---|---|---|
| Founded | 1979 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6M | 7.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MTR | ADIL |
|---|---|---|
| Price | $4.73 | $0.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 2.7K | ★ 345.6K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 4.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $623,288.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.36 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.29 | $0.22 |
| 52 Week High | $10.42 | $1.30 |
Technical Indicators
Market Signals| Indicator | MTR | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 51.36 | 38.91 |
| Support Level | $4.58 | $0.30 |
| Resistance Level | $4.80 | $0.32 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 63.93 | 22.27 |
Price Performance
Historical Comparison MTR
ADIL
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.